Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trial (vol 402, pg 775, 2023)

被引：0
|
作者：
Pozo-Rosich, P.
Ailani, J.
Ashina, M.
机构：
来源：
LANCET | 2023年 / 402卷 / 10404期
关键词：
D O I：
10.1016/S0140-6736(23)01812-3
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：774 / 774
页数：1
相关论文
共 50 条
  • [41] Clarithromycin in the treatment of RSV bronchiolitis: a double-blind, randomised, placebo-controlled trial
    Tahan, F.
    Ozcan, A.
    Koc, N.
    EUROPEAN RESPIRATORY JOURNAL, 2007, 29 (01) : 91 - 97
  • [42] Randomised, double-blind, placebo-controlled trial of corticosteroids for the treatment of hyperemesis gravidarum
    Whittaker, R
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2003, 110 (01) : 88 - 88
  • [43] Guggulu and Triphala for the Treatment of Hypercholesterolaemia: A Placebo-Controlled, Double-Blind, Randomised Trial
    Donato, Francesco
    Raffetti, Elena
    Toninelli, Giuseppe
    Festa, Andrea
    Scarcella, Carmelo
    Castellano, Maurizio
    COMPLEMENTARY MEDICINE RESEARCH, 2021, 28 (03) : 216 - 225
  • [44] Greater occipital nerve blockade for the preventive treatment of chronic migraine: A randomized double-blind placebo-controlled study
    Chowdhury, Debashish
    Tomar, Apoorva
    Deorari, Vaibhav
    Duggal, Ashish
    Krishnan, Anand
    Koul, Arun
    CEPHALALGIA, 2023, 43 (02)
  • [45] Randomised, double-blind, placebo-controlled treatment trial of fluoxetine and graded exercise for chronic fatigue syndrome (vol 172, pg 485, 1998)
    Wearden, AJ
    Morriss, RK
    Mullis, R
    Strickland, PL
    Pearson, DJ
    Appleby, L
    Campbell, IT
    Morris, JA
    BRITISH JOURNAL OF PSYCHIATRY, 1998, 173 : 89 - 89
  • [46] Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial
    Croop, Robert
    Goadsby, Peter J.
    Stock, David A.
    Conway, Charles M.
    Forshaw, Micaela
    Stock, Elyse G.
    Coric, Vladimir
    Lipton, Richard B.
    LANCET, 2019, 394 (10200): : 737 - 745
  • [47] Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine
    Goadsby, Peter J.
    Wietecha, Linda A.
    Dennehy, Ellen B.
    Kuca, Bernice
    Case, Michael G.
    Aurora, Sheena K.
    Gaul, Charly
    BRAIN, 2019, 142 : 1894 - 1904
  • [48] A Randomised, Double-Blind, Placebo-Controlled Crossover Trial of Resveratrol Supplementation for Prophylaxis of Hormonal Migraine
    Dzator, Jemima S. A.
    Howe, Peter R. C.
    Coupland, Kirsten G.
    Wong, Rachel H. X.
    NUTRIENTS, 2022, 14 (09)
  • [49] Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial
    van Schaik, Ivo N.
    Bril, Vera
    van Geloven, Nan
    Hartung, Hans-Peter
    Lewis, Richard A.
    Sobue, Gen
    Lawo, John-Philip
    Praus, Michaela
    Mielke, Orell
    Durn, Billie L.
    Cornblath, David R.
    Merkies, Ingemar S. J.
    LANCET NEUROLOGY, 2018, 17 (01): : 35 - 46
  • [50] A Phase 2/3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rimegepant for the Preventive Treatment of Migraine
    Croop, R.
    Lipton, R. B.
    Kudrow, D.
    Stock, D. A.
    Kamen, L.
    Conway, C. M.
    Stock, E. G.
    Coric, V.
    Goadsby, P. J.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 28 - 29
12345